Moneycontrol PRO

India will be risking economic hara-kiri, if lockdown extended for much longer: Anand Mahindra

"A functioning & growing economy is like an immune system for livelihoods. A lockdown weakens that immune system and most hurts the impoverished in our society," Mahindra said.

May 11, 2020 / 07:17 PM IST

Leading industrialist Anand Mahindra on Monday said that if lockdown is extended for much longer duration then the country will be "risking economic hara-kiri". The Mahindra Group chairman said that while the lockdown has been able to save lakhs of lives, its further extension could lead to severe difficulties for weaker sections of the society.

"The number of new cases has risen, despite flattening the previous few days. With higher testing, a continuing rise is inevitable given the low absolute number of cases relative to our population & the rest of the world. We shouldn't expect a swift flattening of the curve," Mahindra said in a tweet.

But this doesn't mean the lockdown hasn't helped, he added.

"India's avoided lakhs of potential deaths in its collective fight. India's death rate per million is currently 1.4 compared to the global average at 35 & the US at 228. We've also bought time to enhance medical infrastructure," Mahindra noted.

But if the lockdown is extended for much longer, the country will be risking economic hara-kiri, he tweeted.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"A functioning & growing economy is like an immune system for livelihoods. A lockdown weakens that immune system and most hurts the impoverished in our society," he said.

Mahindra said that the country's goal should be to continue preventing avoidable deaths.

The country needs to rapidly build field hospitals equipped with oxygen lines, deploy widespread testing and tracing, he tweeted.

Besides, the focus should be on containment not through zones but at sub pin code levels, he added.

And finally, effort should be made to protect the elderly and the medically vulnerable sections of the society, Mahindra said.

"We have to live with the virus. It's not here on a tourist visa with an expiry date," Mahindra tweeted quoting a colleague.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: May 11, 2020 07:12 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark